Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Teva pharmaceutical industries ltd crawled time : 10:00 save search
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
Published: 2024-02-26 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 11.35%
H: 0.84%
C: -3.25%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 0.0%
H: 1.6%
C: -0.49%
million
Ibuprofen API Market Records Growth of USD 31.68 million from 2022 to 2027, Major Innovations and Key Vendor Offerings - Technavio
Published: 2024-01-23 (Crawled : 10:00) - prnewswire.com
MNKPF | News | $17.25
|
n/a
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
MNKKQ | News | $0.02
|
Manufacturing
| Email alert
Add to watchlist
MNKTQ | News | $0.12 -66.67% 39K
|
Manufacturing
| Email alert
Add to watchlist
MNK | News | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
million key growth market
New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity
Published: 2023-12-06 (Crawled : 10:00) - biospace.com/
TEVA | $13.09 -1.06% 3.2M
|
Health Technology
|
| O: 0.1%
H: 1.09%
C: -2.38%
ajovy obesity migraine
Global Acute Myeloid Leukemia (AML) Treatment Market Trends Analysis Report 2023-2028 - Personalized Medicine and Patient Advocacy Drive Opportunities
Published: 2023-10-20 (Crawled : 10:00) - prnewswire.com
ALPMF | $9.48 1.7K
|
Health Technology
|
| O: -4.45%
H: 0.0%
C: 0.0%
SNYNF | $92.966 630
|
Health Technology
|
| O: -3.95%
H: 0.0%
C: -0.72%
ALPMY | $9.2715 500K
|
Manufacturing
|
| O: -2.89%
H: 3.67%
C: 2.85%
GSK | $39.935 -1.4% 900K
|
Health Technology
|
| O: 0.42%
H: 0.54%
C: 0.11%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
AMGN | $264.99 -0.2% 410K
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -0.64%
report treatment global trends leukemia market
The Glioblastoma Multiforme (GBM) Treatment Market Overview: Market Size, Expected CAGR, Growth Driver And Major Players
Published: 2023-04-13 (Crawled : 10:00) - prnewswire.com
AZNCF | $135.94 770
|
Health Technology
|
| O: 0.0%
H: 1.63%
C: 1.63%
NVSEF | $93.6375 82K
|
Health Technology
|
| O: 1.25%
H: 0.51%
C: 0.51%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: 1.3%
H: 0.56%
C: 0.51%
AZN | $68.39 -0.5% 1.1M
|
Health Technology
|
| O: 0.39%
H: 1.05%
C: 0.97%
AMGN | $264.99 -0.2% 410K
|
Health Technology
|
| O: -0.36%
H: 1.33%
C: 1.14%
expected treatment growth glioblastoma market
Alvotech Provides Update on Corporate Sustainability Framework
Published: 2023-03-28 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: -0.3%
H: 2.0%
C: -2.0%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 0.0%
H: 0.7%
C: -1.3%
update
Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes
Published: 2023-02-27 (Crawled : 10:00) - biospace.com/
TEVA | $13.09 -1.06% 3.2M
|
Health Technology
|
| O: 0.81%
H: 0.4%
C: -0.9%
offering teva
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026
Published: 2023-02-27 (Crawled : 10:00) - biospace.com/
TEVA | $13.09 -1.06% 3.2M
|
Health Technology
|
| O: 0.81%
H: 0.4%
C: -0.9%
teva
Alvotech enters into commercialization agreement with Advanz Pharma for proposed biosimilar to Xolair® (omalizumab)
Published: 2023-02-06 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 0.16%
H: 5.45%
C: 3.9%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: -2.35%
H: 0.0%
C: -1.53%
xolair pharma biosimilar commercialization agreement
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia
Published: 2023-01-24 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: -1.34%
H: 2.21%
C: 0.85%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: -2.73%
avt02 approval
Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate
Published: 2023-01-13 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 0.42%
H: 7.8%
C: 4.56%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: -0.59%
H: 0.79%
C: 0.59%
partnership pharma candidate biosimilar
Alvotech Initiates Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Published: 2023-01-11 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 0.0%
H: 0.08%
C: -0.58%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.23%
H: 0.09%
C: -0.39%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 1.02%
H: 8.69%
C: 6.06%
avt05 simponi biosimilar study
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
Published: 2023-01-06 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 5.27%
H: 4.54%
C: 1.42%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.74%
H: 0.44%
C: 0.07%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: -0.68%
H: 3.69%
C: 3.21%
avt04 stelara biosimilar teva application license
Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®
Published: 2022-12-22 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 16.87%
H: 9.79%
C: 0.41%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: -2.48%
avt02 humira biosimilar update
Alvotech Completes $59.7 Million Private Placement
Published: 2022-12-16 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: -3.75%
H: 5.26%
C: 0.0%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: -0.25%
H: 0.99%
C: -3.95%
Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe
Published: 2022-12-07 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 0.44%
H: 9.12%
C: 8.25%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: -0.87%
H: 0.88%
C: 0.66%
hukyndra europe biosimilar
Alvotech to Present Switching Study Data for AVT02, a Proposed Biosimilar to Humira®, at 2022 American College of Rheumatology Conference
Published: 2022-11-10 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 2.65%
H: 2.75%
C: 2.75%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 2.09%
H: 1.82%
C: 0.0%
avt02 humira conference biosimilar study
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care
Published: 2022-10-19 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: -2.62%
H: 2.54%
C: 0.15%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: -1.52%
H: 3.31%
C: -0.44%
partnership care pharma biosimilar
Alvotech’s Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan
Published: 2022-10-17 (Crawled : 10:00) - globenewswire.com
ALVO | $12.55 0.4% 72K
|
n/a
|
| O: 0.44%
H: 7.05%
C: 2.64%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 2.74%
H: 0.89%
C: 0.0%
candidate biosimilar japan application approval
Alvotech Reports Update on Initial AVT02 Biologics License Application
Published: 2022-09-05 (Crawled : 10:00) - globenewswire.com
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
| Email alert
Add to watchlist
ALVO | $12.55 0.4% 72K
|
n/a
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
avt02 application license update
Gainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.